Magnesium Sulfate Reduces Carrageenan-Induced Rat Paw Inflammatory Edema Via Nitric Oxide Production
Background Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS) in different protocols of use and the possible mechanism of its action. Methods In a rat model of carrageenan-induced paw inflammation, the...
Saved in:
Published in: | Dose-response Vol. 21; no. 1; p. 15593258231155788 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Los Angeles, CA
SAGE Publications
01-01-2023
SAGE PUBLICATIONS, INC SAGE Publishing |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background
Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS) in different protocols of use and the possible mechanism of its action.
Methods
In a rat model of carrageenan-induced paw inflammation, the anti-edematous activity of MS was assessed with a plethysmometer. The effects of the nonselective inhibitor (L-NAME), selective inhibitor of neuronal (L-NPA) and inducible (SMT) nitric oxide synthase on the effects of MS were evaluated.
Results
MS administered systemically before or after inflammation reduced edema by 30% (5 mg/kg, P < .05) and 55% (30 mg/kg, P < .05). MS administered locally (.5 mg/paw, P < .05) significantly prevented the development of inflammatory edema by 60%. L-NAME, intraperitoneally administered before MS, potentiated (5 mg/kg, P < .05) or reduced (3 mg/kg, P < .05), while in the highest tested dose L-NPA (2 mg/kg, P < .01) and SMT (.015 mg/kg, P < .01) reduced the anti-edematous effect of MS.
Conclusions
Magnesium is a more effective anti-edematous drug in therapy than for preventing inflammatory edema. The effect of MS is achieved after systemic and local peripheral administration and when MS is administered as a single drug in a single dose. This effect is mediated at least in part via the production of nitric oxide. |
---|---|
AbstractList | BackgroundMagnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS) in different protocols of use and the possible mechanism of its action. MethodsIn a rat model of carrageenan-induced paw inflammation, the anti-edematous activity of MS was assessed with a plethysmometer. The effects of the nonselective inhibitor (L-NAME), selective inhibitor of neuronal (L-NPA) and inducible (SMT) nitric oxide synthase on the effects of MS were evaluated. ResultsMS administered systemically before or after inflammation reduced edema by 30% (5 mg/kg, P < .05) and 55% (30 mg/kg, P < .05). MS administered locally (.5 mg/paw, P < .05) significantly prevented the development of inflammatory edema by 60%. L-NAME, intraperitoneally administered before MS, potentiated (5 mg/kg, P < .05) or reduced (3 mg/kg, P < .05), while in the highest tested dose L-NPA (2 mg/kg, P < .01) and SMT (.015 mg/kg, P < .01) reduced the anti-edematous effect of MS. ConclusionsMagnesium is a more effective anti-edematous drug in therapy than for preventing inflammatory edema. The effect of MS is achieved after systemic and local peripheral administration and when MS is administered as a single drug in a single dose. This effect is mediated at least in part via the production of nitric oxide. Background Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS) in different protocols of use and the possible mechanism of its action. Methods In a rat model of carrageenan-induced paw inflammation, the anti-edematous activity of MS was assessed with a plethysmometer. The effects of the nonselective inhibitor (L-NAME), selective inhibitor of neuronal (L-NPA) and inducible (SMT) nitric oxide synthase on the effects of MS were evaluated. Results MS administered systemically before or after inflammation reduced edema by 30% (5 mg/kg, P < .05) and 55% (30 mg/kg, P < .05). MS administered locally (.5 mg/paw, P < .05) significantly prevented the development of inflammatory edema by 60%. L-NAME, intraperitoneally administered before MS, potentiated (5 mg/kg, P < .05) or reduced (3 mg/kg, P < .05), while in the highest tested dose L-NPA (2 mg/kg, P < .01) and SMT (.015 mg/kg, P < .01) reduced the anti-edematous effect of MS. Conclusions Magnesium is a more effective anti-edematous drug in therapy than for preventing inflammatory edema. The effect of MS is achieved after systemic and local peripheral administration and when MS is administered as a single drug in a single dose. This effect is mediated at least in part via the production of nitric oxide. Background Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS) in different protocols of use and the possible mechanism of its action. Methods In a rat model of carrageenan-induced paw inflammation, the anti-edematous activity of MS was assessed with a plethysmometer. The effects of the nonselective inhibitor (L-NAME), selective inhibitor of neuronal (L-NPA) and inducible (SMT) nitric oxide synthase on the effects of MS were evaluated. Results MS administered systemically before or after inflammation reduced edema by 30% (5 mg/kg, P < .05) and 55% (30 mg/kg, P < .05). MS administered locally (.5 mg/paw, P < .05) significantly prevented the development of inflammatory edema by 60%. L-NAME, intraperitoneally administered before MS, potentiated (5 mg/kg, P < .05) or reduced (3 mg/kg, P < .05), while in the highest tested dose L-NPA (2 mg/kg, P < .01) and SMT (.015 mg/kg, P < .01) reduced the anti-edematous effect of MS. Conclusions Magnesium is a more effective anti-edematous drug in therapy than for preventing inflammatory edema. The effect of MS is achieved after systemic and local peripheral administration and when MS is administered as a single drug in a single dose. This effect is mediated at least in part via the production of nitric oxide. Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS) in different protocols of use and the possible mechanism of its action. In a rat model of carrageenan-induced paw inflammation, the anti-edematous activity of MS was assessed with a plethysmometer. The effects of the nonselective inhibitor (L-NAME), selective inhibitor of neuronal (L-NPA) and inducible (SMT) nitric oxide synthase on the effects of MS were evaluated. MS administered systemically before or after inflammation reduced edema by 30% (5 mg/kg, < .05) and 55% (30 mg/kg, < .05). MS administered locally (.5 mg/paw, < .05) significantly prevented the development of inflammatory edema by 60%. L-NAME, intraperitoneally administered before MS, potentiated (5 mg/kg, < .05) or reduced (3 mg/kg, < .05), while in the highest tested dose L-NPA (2 mg/kg, < .01) and SMT (.015 mg/kg, < .01) reduced the anti-edematous effect of MS. Magnesium is a more effective anti-edematous drug in therapy than for preventing inflammatory edema. The effect of MS is achieved after systemic and local peripheral administration and when MS is administered as a single drug in a single dose. This effect is mediated at least in part via the production of nitric oxide. Background Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS) in different protocols of use and the possible mechanism of its action. Methods In a rat model of carrageenan-induced paw inflammation, the anti-edematous activity of MS was assessed with a plethysmometer. The effects of the nonselective inhibitor (L-NAME), selective inhibitor of neuronal (L-NPA) and inducible (SMT) nitric oxide synthase on the effects of MS were evaluated. Results MS administered systemically before or after inflammation reduced edema by 30% (5 mg/kg, P < .05) and 55% (30 mg/kg, P < .05). MS administered locally (.5 mg/paw, P < .05) significantly prevented the development of inflammatory edema by 60%. L-NAME, intraperitoneally administered before MS, potentiated (5 mg/kg, P < .05) or reduced (3 mg/kg, P < .05), while in the highest tested dose L-NPA (2 mg/kg, P < .01) and SMT (.015 mg/kg, P < .01) reduced the anti-edematous effect of MS. Conclusions Magnesium is a more effective anti-edematous drug in therapy than for preventing inflammatory edema. The effect of MS is achieved after systemic and local peripheral administration and when MS is administered as a single drug in a single dose. This effect is mediated at least in part via the production of nitric oxide. |
Author | Savić Vujović, Katarina Srebro, Dragana Dožić, Branko Vučković, Sonja Medić Brkić, Branislava |
Author_xml | – sequence: 1 givenname: Dragana orcidid: 0000-0002-9680-0840 surname: Srebro fullname: Srebro, Dragana email: srebrodragana1@gmail.com organization: Department of Pathology, School of Dental Medicine – sequence: 2 givenname: Branko surname: Dožić fullname: Dožić, Branko organization: Department of Pathology, School of Dental Medicine – sequence: 3 givenname: Katarina orcidid: 0000-0002-4701-6291 surname: Savić Vujović fullname: Savić Vujović, Katarina organization: Department of Pathology, School of Dental Medicine – sequence: 4 givenname: Branislava orcidid: 0000-0001-7012-6766 surname: Medić Brkić fullname: Medić Brkić, Branislava organization: Department of Pathology, School of Dental Medicine – sequence: 5 givenname: Sonja surname: Vučković fullname: Vučković, Sonja organization: Department of Pathology, School of Dental Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36756149$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kktv1DAUhSNURB_wA9ggS2zYTPEzjjdIaFTKSIVW5bG1buObwaPEbu0E2n-Pw5TSglj56vicz7723a92QgxYVc8ZPWRM69dMKSO4arhgpdRN86jam7XFLO7cq3er_Zw3lEqlBXtS7Ypaq5pJs1e5D7AOmP00kE9T38GI5Bzd1GImS0gJ1ogBwmIVZs2RcxjJGfwgq9D1MAwwxnRDjhwOQL56IB_9mHxLTq-9Q3KWYgmNPoan1eMO-ozPbteD6su7o8_L94uT0-PV8u3JolWCjwvDHG1KR7rjVGp9ITtpBHXOdbVCozvHtTESmQJoqXHIGi4FItaNVsYxKQ6q1ZbrImzsZfIDpBsbwdtfQkxrC2n0bY-W1y2IhjeArJVtydPOKM7A1YLxuuOF9WbLupwuBnQthjFB_wD6cCf4b3Ydv1tjKK31DHh1C0jxasI82sHnFvseAsYpW661bIyWzBTry7-smzilUJ6quAxvBJNqBrKtq00x54Td3WUYtfM82H_moWRe3O_iLvF7AIrhcGvI5av_HPt_4k8Ptr5d |
CitedBy_id | crossref_primary_10_1016_j_niox_2024_02_005 crossref_primary_10_1016_j_jep_2024_118216 crossref_primary_10_3390_ijms24076241 |
Cites_doi | 10.1371/journal.pone.0135558 10.1096/fasebj.7.13.8405815 10.1016/j.ejphar.2018.07.022 10.1684/mrh.2014.0364 10.1007/s10787-017-0361-0 10.1016/j.neuroscience.2016.09.032 10.1016/S0006-8993(01)03240-1 10.1007/BF02024731 10.1038/srep00380 10.1007/BF00178952 10.1016/S0024-3205(02)02371-8 10.1007/s10787-018-0526-5 10.5812/aapm.16316 10.1007/s11011-019-00419-y 10.1248/bpb.30.1934 10.1177/15593258221103846 10.1111/j.1476-5381.1971.tb07124.x 10.3389/neuro.01.024.2009 10.1007/BF01993127 10.1016/S0014-2999(03)01604-2 10.3109/13880209.2014.996821 10.1038/nature01320 10.1161/01.HYP.0000146536.68208.84 10.4049/jimmunol.166.2.1169 10.3390/nu14030679 10.1016/S0006-8993(01)02733-0 10.1016/j.physbeh.2014.11.042 10.2174/0929867323666161213101744 10.3389/fmed.2022.923282 10.1186/ar2208 10.1016/j.abb.2006.03.031 10.1017/S0007114510003107 10.1016/j.pharep.2017.08.005 10.1016/0304-3959(95)00113-1 10.1016/S0014-2999(02)02119-2 |
ContentType | Journal Article |
Copyright | The Author(s) 2023 The Author(s) 2023. The Author(s) 2023. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2023 2023 SAGE Publications |
Copyright_xml | – notice: The Author(s) 2023 – notice: The Author(s) 2023. – notice: The Author(s) 2023. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2023 2023 SAGE Publications |
DBID | AFRWT NPM AAYXX CITATION 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1177/15593258231155788 |
DatabaseName | Sage Journals GOLD Open Access 2024 PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef PubMed Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1559-3258 |
EndPage | 15593258231155788 |
ExternalDocumentID | oai_doaj_org_article_26ca3828ae1c4c7590f9521ad63126f2 10_1177_15593258231155788 36756149 10.1177_15593258231155788 |
Genre | Journal Article |
GrantInformation_xml | – fundername: The Ministry of Education and Science of the Republic of Serbia grantid: Grant No. 200110 – fundername: ; grantid: Grant No. 200110 |
GroupedDBID | --- 0R~ 29G 2WC 31X 53G 54M 5GY 5VS 7X7 8FI 8FJ AAFWJ AAJPV AAJQC AAKDD AAQQG AATBZ ABAWP ABDBF ABJIS ABNCE ABQXT ABUWG ABVFX ABXGC ACARO ACDXX ACGFS ACGZU ACROE ACSIQ ADBBV ADOGD AENEX AEUHG AEUIJ AEWDL AEWHI AFCOW AFKRA AFKRG AFPKN AFRWT AJUZI ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS ARTOV AUTPY AYAKG B0M BAWUL BCNDV BDDNI BENPR BPHCQ BSEHC BVXVI CCPQU CS3 DC. DIK DU5 DV7 E3Z EAP EBD EBS EDH EMK ESX FYUFA GROUPED_DOAJ GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION GX1 HMCUK HYE J8X K.F KQ8 M4V MET MK0 M~E O9- OK1 PIMPY PQQKQ ROL RPM SFC SFK SFT SGV SPP TR2 TUS UKHRP ~8M 4.4 EJD H13 IPNFZ NPM RIG AAYXX CITATION 3V. 7XB 8FK AZQEC DWQXO K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c532t-91d085937f20477b4f4930dddf65e97fd27994e15aac09de18243eee68759d143 |
IEDL.DBID | RPM |
ISSN | 1559-3258 |
IngestDate | Tue Oct 22 14:53:30 EDT 2024 Tue Sep 17 21:30:31 EDT 2024 Fri Oct 25 00:41:59 EDT 2024 Thu Oct 10 20:09:42 EDT 2024 Wed Oct 09 16:47:29 EDT 2024 Sat Sep 28 08:22:14 EDT 2024 Tue Jul 16 20:39:07 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | preemptive therapy anti-inflammatory emptive therapy magnesium anti-edematous NOS inhibitors |
Language | English |
License | This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). The Author(s) 2023. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c532t-91d085937f20477b4f4930dddf65e97fd27994e15aac09de18243eee68759d143 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-9680-0840 0000-0001-7012-6766 0000-0002-4701-6291 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900672/ |
PMID | 36756149 |
PQID | 2792831452 |
PQPubID | 4450826 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_26ca3828ae1c4c7590f9521ad63126f2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9900672 proquest_miscellaneous_2774897419 proquest_journals_2792831452 crossref_primary_10_1177_15593258231155788 pubmed_primary_36756149 sage_journals_10_1177_15593258231155788 |
PublicationCentury | 2000 |
PublicationDate | 2023-01-01 |
PublicationDateYYYYMMDD | 2023-01-01 |
PublicationDate_xml | – month: 01 year: 2023 text: 2023-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Los Angeles, CA |
PublicationPlace_xml | – name: Los Angeles, CA – name: United States – name: Thousand Oaks – name: Sage CA: Los Angeles, CA |
PublicationTitle | Dose-response |
PublicationTitleAlternate | Dose Response |
PublicationYear | 2023 |
Publisher | SAGE Publications SAGE PUBLICATIONS, INC SAGE Publishing |
Publisher_xml | – name: SAGE Publications – name: SAGE PUBLICATIONS, INC – name: SAGE Publishing |
References | Fujii, Irie, Uchida, Tsukahara, Muraki 1994; 350 Morris 2003; 225 Shadman, Sadeghian, Moradi, Bohlooli, Panahpour 2019; 34 Gupta, Parasar, Sagar 2015; 10 Aryana, Rajaei, Bagheri, Karimi, Dabbagh 2014; 4 Masini, Salvemini, Pistelli, Mannaioni, Vane 1991; 33 Infante, Díaz, Hernández, Constandil, Pelissier 2007; 9 Nathan 2002; 420 Srebro, Vučković, Vujović, Prostran 2014; 27 Vuckovic, Srebro, Savic Vujovic, Prostran 2015; 53 Freire, Guimarães, Leal, Pereira 2009; 3 Crunkhorn, Meacock 1971; 42 Mazur, Maier, Rock, Gueux, Nowacki, Rayssiguier 2007; 458 Oliveira, de Almeida, de Oliveira 2018; 834 Veronese, Pizzol, Smith, Dominguez, Barbagallo 2022; 14 Yokoyama, Oono, Miyamoto, Ishiguro, Nishio 2003; 72 Otterness, Wiseman, Gans 1979; 9 Shimosawa, Takano, Ando, Fujita 2004; 44 Srebro, Vučković, Savić Vujović, Prostran 2015; 139 Xiang, Ji, Jiang, Huang, Yan 2022; 9 Paul-Clark, Gilroy, Willis, Willoughby, Tomlinson 2001; 166 Tandoh, Danquah, Benneh, Adongo, Boakye-Gyasi, Woode 2022; 20 Zanchet, Cury 2003; 467 Sawynok, Reid 2002; 450 Felsby, Nielsen, Arendt-Nielsen, Jensen 1996; 64 Srebro, Vuckovic, Milovanovic, Kosutic, Vujovic, Prostran 2017; 24 Omote, Hazama, Kawamata 2001; 912 Kubes, Kanwar, Niu, Gaboury 1993; 7 Nagai, Fukuhata, Ito, Tai, Hataguchi, Nakagawa 2007; 30 Srebro, Vučković, Dožić 2018; 70 Moilanen, Laavola, Kukkonen 2012; 2 Guiet-Bara, Durlach, Bara 2007; 20 Srebro, Vučković, Milovanović, Vujović, Vučetić, Prostran 2019; 27 Srebro, Vučković, Prostran 2016; 339 Jarosz, Szkaradek, Marona, Nowak, Młyniec, Librowski 2017; 25 Beirith, Santos, Calixto 2002; 924 Odabasoglu, Halici, Aygun 2011; 105 bibr26-15593258231155788 bibr36-15593258231155788 bibr8-15593258231155788 bibr3-15593258231155788 bibr30-15593258231155788 bibr29-15593258231155788 bibr19-15593258231155788 bibr6-15593258231155788 bibr10-15593258231155788 bibr16-15593258231155788 bibr33-15593258231155788 bibr20-15593258231155788 bibr23-15593258231155788 bibr13-15593258231155788 bibr21-15593258231155788 bibr31-15593258231155788 bibr34-15593258231155788 bibr11-15593258231155788 bibr14-15593258231155788 bibr27-15593258231155788 bibr24-15593258231155788 bibr17-15593258231155788 bibr37-15593258231155788 bibr4-15593258231155788 bibr7-15593258231155788 bibr32-15593258231155788 bibr1-15593258231155788 bibr28-15593258231155788 bibr2-15593258231155788 bibr9-15593258231155788 bibr5-15593258231155788 bibr15-15593258231155788 bibr25-15593258231155788 bibr35-15593258231155788 bibr22-15593258231155788 Morris C (bibr18-15593258231155788) 2003; 225 Guiet-Bara A (bibr12-15593258231155788) 2007; 20 |
References_xml | – volume: 2 start-page: 380 year: 2012 article-title: TRPA1 contributes to the acute inflammatory response and mediates carrageenan-induced paw edema in the mouse publication-title: Sci Rep contributor: fullname: Kukkonen – volume: 3 start-page: 175 issue: 2 year: 2009 end-page: 181 article-title: Pain modulation by nitric oxide in the spinal cord publication-title: Front Neurosci contributor: fullname: Pereira – volume: 33 start-page: 61 issue: 1-2 year: 1991 end-page: 63 article-title: Rat mast cells synthesize a nitric oxide like-factor which modulates the release of histamine publication-title: Agents Actions contributor: fullname: Vane – volume: 225 start-page: 115 year: 2003 end-page: 121 article-title: Carrageenan-induced paw edema in the rat and mouse publication-title: Methods Mol Biol contributor: fullname: Morris – volume: 139 start-page: 267 year: 2015 end-page: 273 article-title: TRPA1, NMDA receptors and nitric oxide mediate mechanical hyperalgesia induced by local injection of magnesium sulfate into the rat hind paw publication-title: Physiol Behav contributor: fullname: Prostran – volume: 25 start-page: 653 issue: 6 year: 2017 end-page: 663 article-title: Evaluation of anti-inflammatory and ulcerogenic potential of zinc-ibuprofen and zinc-naproxen complexes in rats publication-title: Inflammopharmacology contributor: fullname: Librowski – volume: 30 start-page: 1934 issue: 10 year: 2007 end-page: 1937 article-title: Preventive effect of water containing magnesium ion on paw edema in adjuvant-induced arthritis rat publication-title: Biol Pharm Bull contributor: fullname: Nakagawa – volume: 64 start-page: 283 issue: 2 year: 1996 end-page: 291 article-title: NMDA receptor blockade in chronic neuropathic pain: A comparison of ketamine and magnesium chloride publication-title: Pain contributor: fullname: Jensen – volume: 70 start-page: 81 issue: 1 year: 2018 end-page: 86 article-title: Magnesium sulfate reduces formalin-induced orofacial pain in rats with normal magnesium serum levels publication-title: Pharmacol Rep contributor: fullname: Dožić – volume: 924 start-page: 219 issue: 2 year: 2002 end-page: 228 article-title: Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw publication-title: Brain Res contributor: fullname: Calixto – volume: 912 start-page: 171 issue: 2 year: 2001 end-page: 175 article-title: Peripheral nitric oxide in carrageenan-induced inflammation publication-title: Brain Res contributor: fullname: Kawamata – volume: 458 start-page: 48 issue: 1 year: 2007 end-page: 56 article-title: Magnesium and the inflammatory response: Potential physiopathological implications publication-title: Arch Biochem Biophys contributor: fullname: Rayssiguier – volume: 34 start-page: 1221 issue: 4 year: 2019 end-page: 1229 article-title: Magnesium sulfate protects blood-brain barrier integrity and reduces brain edema after acute ischemic stroke in rats publication-title: Metab Brain Dis contributor: fullname: Panahpour – volume: 166 start-page: 1169 issue: 2 year: 2001 end-page: 1177 article-title: Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration publication-title: J Immunol contributor: fullname: Tomlinson – volume: 10 start-page: e0135558 issue: 8 year: 2015 article-title: Analgesic inflammatory properties of gelsolin in acetic acid induced writhing, tail immersion and carrageenan induced paw edema in mice publication-title: PLoS One contributor: fullname: Sagar – volume: 9 start-page: R53 issue: 3 year: 2007 article-title: Expression of nitric oxide synthase isoforms in the dorsal horn of monoarthritic rats: Effects of competitive and uncompetitive N-methyl-D-aspartate antagonists publication-title: Arthritis Res Ther contributor: fullname: Pelissier – volume: 27 start-page: 121 issue: 1 year: 2019 end-page: 128 article-title: Preventive treatment with dizocilpine attenuates oedema in a carrageenan model of inflammation: The interaction of glutamatergic and nitrergic signaling publication-title: Inflammopharmacology contributor: fullname: Prostran – volume: 350 start-page: 361 issue: 4 year: 1994 end-page: 364 article-title: Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin publication-title: Naunyn-Schmiedeberg’s Arch Pharmacol contributor: fullname: Muraki – volume: 20 start-page: 15593258221103846 issue: 2 year: 2022 article-title: Effect of diclofenac and andrographolide combination on carrageenan-induced paw edema and hyperalgesia in rats publication-title: Dose Response contributor: fullname: Woode – volume: 9 start-page: 177 issue: 2 year: 1979 end-page: 183 article-title: A comparison of the carrageenan edema test and ultraviolet light-induced erythema test as predictors of the clinical dose in rheumatoid arthritis publication-title: Agents Actions contributor: fullname: Gans – volume: 53 start-page: 1621 issue: 11 year: 2015 end-page: 1627 article-title: The antinociceptive effects of magnesium sulfate and MK-801 in visceral inflammatory pain model: The role of NO/cGMP/K(+)ATP pathway publication-title: Pharm Biol contributor: fullname: Prostran – volume: 105 start-page: 31 issue: 1 year: 2011 end-page: 43 article-title: α-Lipoic acid has anti-inflammatory and anti-oxidative properties: An experimental study in rats with carrageenan-induced acute and cotton pellet-induced chronic inflammations publication-title: Br J Nutr contributor: fullname: Aygun – volume: 72 start-page: 1247 issue: 11 year: 2003 end-page: 1257 article-title: Magnesium-deficient medium enhances NO production in alveolar macrophages isolated from rats publication-title: Life Sci contributor: fullname: Nishio – volume: 9 start-page: 923282 year: 2022 article-title: Reduced serum magnesium is associated with the occurrence of diabetic macular edema in patients with diabetic retinopathy: A retrospective study publication-title: Front Med contributor: fullname: Yan – volume: 420 start-page: 846 issue: 6917 year: 2002 end-page: 852 article-title: Points of control in inflammation publication-title: Nature contributor: fullname: Nathan – volume: 450 start-page: 153 issue: 2 year: 2002 end-page: 162 article-title: Modulation of formalin-induced behaviors and edema by local and systemic administration of dextromethorphan, memantine and ketamine publication-title: Eur J Pharmacol contributor: fullname: Reid – volume: 7 start-page: 1293 issue: 13 year: 1993 end-page: 1299 article-title: Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells publication-title: FASEB J contributor: fullname: Gaboury – volume: 24 start-page: 424 issue: 4 year: 2017 end-page: 434 article-title: Magnesium in pain research: State of the art publication-title: Curr Med Chem contributor: fullname: Prostran – volume: 14 start-page: 679 issue: 3 year: 2022 article-title: Effect of magnesium supplementation on inflammatory parameters: A meta-analysis of randomized controlled trials publication-title: Nutrients contributor: fullname: Barbagallo – volume: 4 start-page: e16316 issue: 3 year: 2014 article-title: Acute effect of intravenous administration of magnesium sulfate on serum levels of interleukin-6 and tumor necrosis factor-α in patients undergoing elective coronary bypass graft with cardiopulmonary bypass publication-title: Anesth Pain Med contributor: fullname: Dabbagh – volume: 339 start-page: 1 year: 2016 end-page: 11 article-title: Participation of peripheral TRPV1, TRPV4, TRPA1 and ASIC in a magnesium sulfate-induced local pain model in rat publication-title: Neuroscience contributor: fullname: Prostran – volume: 467 start-page: 111 issue: 1-3 year: 2003 end-page: 118 article-title: Peripheral tackykinin and excitatory amino acid receptors mediate hyperalgesia induced by Phoneutria nigriventer venom publication-title: Eur J Pharmacol contributor: fullname: Cury – volume: 27 start-page: 77 issue: 2 year: 2014 end-page: 85 article-title: Anti-hyperalgesic effect of systemic magnesium sulfate in carrageenan-induced inflammatory pain in rats: Influence of the nitric oxide pathway publication-title: Magnes Res contributor: fullname: Prostran – volume: 834 start-page: 54 year: 2018 end-page: 64 article-title: Evaluation of the antinociceptive and anti-inflammatory activities of piperic acid: Involvement of the cholinergic and vanilloid systems publication-title: Eur J Pharmacol contributor: fullname: de Oliveira – volume: 20 start-page: 100 issue: 2 year: 2007 end-page: 106 article-title: Magnesium ions and ionic channels: Activation, inhibition or block—a hypothesis publication-title: Magnes Res contributor: fullname: Bara – volume: 44 start-page: 897 issue: 6 year: 2004 end-page: 902 article-title: Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings publication-title: Hypertension contributor: fullname: Fujita – volume: 42 start-page: 392 issue: 3 year: 1971 end-page: 402 article-title: Mediators of the inflammation induced in the rat paw by carrageenin publication-title: Br J Pharmacol contributor: fullname: Meacock – ident: bibr22-15593258231155788 doi: 10.1371/journal.pone.0135558 – volume: 20 start-page: 100 issue: 2 year: 2007 ident: bibr12-15593258231155788 publication-title: Magnes Res contributor: fullname: Guiet-Bara A – ident: bibr30-15593258231155788 doi: 10.1096/fasebj.7.13.8405815 – ident: bibr37-15593258231155788 doi: 10.1016/j.ejphar.2018.07.022 – ident: bibr4-15593258231155788 doi: 10.1684/mrh.2014.0364 – ident: bibr29-15593258231155788 doi: 10.1007/s10787-017-0361-0 – ident: bibr36-15593258231155788 doi: 10.1016/j.neuroscience.2016.09.032 – ident: bibr26-15593258231155788 doi: 10.1016/S0006-8993(01)03240-1 – ident: bibr17-15593258231155788 doi: 10.1007/BF02024731 – ident: bibr35-15593258231155788 doi: 10.1038/srep00380 – ident: bibr15-15593258231155788 doi: 10.1007/BF00178952 – ident: bibr20-15593258231155788 doi: 10.1016/S0024-3205(02)02371-8 – ident: bibr16-15593258231155788 doi: 10.1007/s10787-018-0526-5 – ident: bibr21-15593258231155788 doi: 10.5812/aapm.16316 – ident: bibr8-15593258231155788 doi: 10.1007/s11011-019-00419-y – volume: 225 start-page: 115 year: 2003 ident: bibr18-15593258231155788 publication-title: Methods Mol Biol contributor: fullname: Morris C – ident: bibr10-15593258231155788 doi: 10.1248/bpb.30.1934 – ident: bibr2-15593258231155788 doi: 10.1177/15593258221103846 – ident: bibr23-15593258231155788 doi: 10.1111/j.1476-5381.1971.tb07124.x – ident: bibr14-15593258231155788 doi: 10.3389/neuro.01.024.2009 – ident: bibr31-15593258231155788 doi: 10.1007/BF01993127 – ident: bibr28-15593258231155788 doi: 10.1016/S0014-2999(03)01604-2 – ident: bibr5-15593258231155788 doi: 10.3109/13880209.2014.996821 – ident: bibr1-15593258231155788 doi: 10.1038/nature01320 – ident: bibr11-15593258231155788 doi: 10.1161/01.HYP.0000146536.68208.84 – ident: bibr34-15593258231155788 doi: 10.4049/jimmunol.166.2.1169 – ident: bibr13-15593258231155788 doi: 10.3390/nu14030679 – ident: bibr24-15593258231155788 doi: 10.1016/S0006-8993(01)02733-0 – ident: bibr33-15593258231155788 doi: 10.1016/j.physbeh.2014.11.042 – ident: bibr6-15593258231155788 doi: 10.2174/0929867323666161213101744 – ident: bibr9-15593258231155788 doi: 10.3389/fmed.2022.923282 – ident: bibr32-15593258231155788 doi: 10.1186/ar2208 – ident: bibr3-15593258231155788 doi: 10.1016/j.abb.2006.03.031 – ident: bibr25-15593258231155788 doi: 10.1017/S0007114510003107 – ident: bibr7-15593258231155788 doi: 10.1016/j.pharep.2017.08.005 – ident: bibr19-15593258231155788 doi: 10.1016/0304-3959(95)00113-1 – ident: bibr27-15593258231155788 doi: 10.1016/S0014-2999(02)02119-2 |
SSID | ssj0045731 |
Score | 2.342746 |
Snippet | Background
Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS)... Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS) in... Background Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS)... BackgroundMagnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS)... |
SourceID | doaj pubmedcentral proquest crossref pubmed sage |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 15593258231155788 |
SubjectTerms | Drug dosages Edema Nitric oxide Special Collection: Inflammatory Parameters as Early Biomarkers in Prediction and Monitoring of Therapeutic Effects in Preclinical and Clinical Studies |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA96T4KI31ZPiSAIQrH5apJHPfc4HzyPOxXfSrYz0YLbk90t-uc7abp7Lqf44lvphDLMTOYjk_6GsWd164VxlS5la7HUIOvSg1IlxNY7A4gSUqF4dGaPP7s3swSTsx31le6EZXjgLLiXsm6DorIgoGh1a42voqeQE6BWQtYxe9_KbYqp7IO1sUpMPcwEr5R6b0qa1PKiRzuOWbmIQiNY_58yzMsXJX-77TUGoMOb7MaUOfJXmeNb7Ar2t9n1fOzG899Edxi8C1_IeXXDgp8N3yIlkvw0gbPiih-E5ZI-i33oyzSwo0Xgp2HNT8IP_raPZBmLsePOZ4CLwD91gR93Cb-fv__ZAfKTjA1LerzLPh7OPhwcldMghbI1Sq7JocGIa2ajrLS1cx21VxUAxNqgtxGk9V6jMCG0lQekmkMrRKypmPFAGdU9ttef9_iA8blAR_7R--iFxhjmmlIWBwIjKhucK9iLjWCb7xkvoxETpPglLRTsdRL9dmGCuh5fkAE0kwE0_zKAgu1vFNdM-2_VJFhEp4Q2RH66JdPOSe2Q0OP5kNYk5B3KqHzB7mc9bzlRVEdR4kIUu2MBO6zuUvru64jOTeE9tbcL9jzZygVLf5XCw_8hhUfsmqT0Kx8O7bO99XLAx-zqCoYn4874BfvmDVI priority: 102 providerName: Directory of Open Access Journals |
Title | Magnesium Sulfate Reduces Carrageenan-Induced Rat Paw Inflammatory Edema Via Nitric Oxide Production |
URI | https://journals.sagepub.com/doi/full/10.1177/15593258231155788 https://www.ncbi.nlm.nih.gov/pubmed/36756149 https://www.proquest.com/docview/2792831452 https://search.proquest.com/docview/2774897419 https://pubmed.ncbi.nlm.nih.gov/PMC9900672 https://doaj.org/article/26ca3828ae1c4c7590f9521ad63126f2 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfonpAQ4pvAmIyEhISUtf5IHD9C6TQeNqoNEG-Ra59HpCWd2kbbn8_ZSTqqwQtvUWwlJ9_5_Dvf-WdC3uVWs6yYyJRbBal0PE-1EyJ13uoicwDchUDx-Fyd_iw-zwJNTjachYlF-3ZRHTaX9WFT_Yq1lVe1HQ91YuP5yRQ9aMggjkdkhNhwCNE79yszJVifvgzMSiHtJngWsl34qOINK7cLUOTp_xu4vFsj-UehV1x7jh6Rhz1opB874R6Te9A8IQ-6HTfaHSR6StyJuUC_VbU1PW8vPWJIehZ4WWFNp2a1ws9CY5o03NVhwdEzs6Fzc02_NB6Noo7JdjpzUBv6ozL0tArU_fTrTeWAzjtaWFThM_L9aPZtepz2dyikNhN8g77MRUoz5flEKrWQXmoxcc75PAOtvONKawksM8ZOtAMMN6QAgBzjGO0QTD0ne82ygZeELhgU6Bq19ppJ8GYhEa0UjoEHoUxRJOTDMLDlVUeVUbKeTfyOFhLyKQz9tmNguY4vlquLstd1yXNrBIaEBpiVFgWaeI1ww7hcMJ57npD9QXFlP_XWZWBELASTGTa_3TbjpAmZENPAsg19AukOgimdkBednreSCAyhELNgi9qxgB1Rd1vQTiMxd2-XCXkfbOVWpH-Owqv__sdrcj9cfN9tBu2Tvc2qhTdktHbtQdxWOIiT4jfclg3D |
link.rule.ids | 230,315,729,782,786,866,887,2108,27935,27936,53803,53805 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfYeAAJ8T0IDDASEhJS1sR24vgRSqdOrKXaBuItcu3ziLSkU9sI_nzO-eioBi97i3KWcsqdz7_znX8m5F1qVJxkkQiZkRAKy9JQWc5D64zKEgvArE8Ux6dy-iP7PPI0OUl_FqZp2jfz4qC6KA-q4mfTW3lZmkHfJzaYTYYYQX0FcbBDbuN8jXifpLcBWCSSx10B03Mr-cIbZ4mvd-GjbO5YuVqCGqb-f8HL612Sf7V6NavP4YMb6v2Q3O_gJv3Yih-RW1A9JvfavTraHkF6QuxEn2PEK-qSntYXDtEnPfGMrrCiQ71cojpQ6Sr0t3wYsPREr-lM_6JHlUN3KpsyPR1ZKDX9Xmg6LTzpP_36u7BAZy2hLBr_Kfl2ODobjsPu9oXQJJytMQrahgxNOhYJKefCCcUja61LE1DSWSaVEhAnWptIWcBERXAASDEDUhZh2B7ZrRYVPCd0HkOGQVUpp2IBTs8F4pzMxuCAS51lAfnQGyS_bEk28rjjIb9mvYB88ibbDPT82M2LxfI87_52zlKjOSaTGmIjDCoUOYVARduUxyx1LCD7vcHzbtKucs-lmPFYJCh-uxHjdPM1FF3BovZjPF0PwjAVkGetf2w04Zh8IdpBidzynC1VtyXoKQ2ld-cZAXnvfexKpf_-hRc3_sYbcmd8NjnOj4-mX16SuwxBW7ultE9218saXpGdla1fN1PqD3ZkIlo |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYkBASGt8sMMBISEhIWeOPxPEjdK02wUq1AeItcu3ziLSkVT8Efz7nJO2oBi_wFuUs5WSfz7_zXX5HyOvMapbmiYy5VRBLx7NYOyFi563OUwfAXQgUj8_V6Ft-NAg0OZtWX03Rvp2Uh_VldViX35vayllle-s6sd74tI8eNGQQezPnezvkJu7ZJF0H6q0TlqkSrEtiBn6lkHwTPA05L3xUTZ-Vq2OoYev_E8S8Xin5W7lXcwIN7_6H7vfIXgc76bt2yH1yA-oH5E57Z0fbX5EeEndqLtDzlauKnq8uPaJQehaYXWFB-2Y-R5WgNnUcun1YcPTMLOnY_KAntUezqpp0PR04qAz9Who6KgP5P_30s3RAxy2xLBrBI_JlOPjcP467LgyxTQVfojd0DSma8jyRSk2kl1okzjmfpaCVd1xpLYGlxthEO8CARQoAyDAS0g7h2GOyW09r2Cd0wiBH56q110yCNxOJeCd3DDwIZfI8Im_Xi1LMWrKNgnV85NdWMCLvw7JtBgae7ObFdH5RdDNe8MwagUGlAWalRYUSrxGwGJcJxjPPI3KwXvSi27yLInAq5oLJFMWvNmLcdiGXYmqYrsKYQNuDcExH5ElrIxtNBAZhiHpQorasZ0vVbQlaS0Pt3VlHRN4EO7tS6a-z8PSfv_GS3BofDYuPJ6MPz8htjtitvVk6ILvL-Qqek52FW71odtUvsUok2g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Magnesium+Sulfate+Reduces+Carrageenan-Induced+Rat+Paw+Inflammatory+Edema+Via+Nitric+Oxide+Production&rft.jtitle=Dose-response&rft.au=Srebro+Dragana&rft.au=Do%C5%BEi%C4%87+Branko&rft.au=Savi%C4%87%2C+Vujovi%C4%87+Katarina&rft.au=Branislava%2C+Medi%C4%87+Brki%C4%87&rft.date=2023-01-01&rft.pub=SAGE+PUBLICATIONS%2C+INC&rft.eissn=1559-3258&rft.volume=21&rft.issue=1&rft_id=info:doi/10.1177%2F15593258231155788 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1559-3258&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1559-3258&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1559-3258&client=summon |